TobaccoIntelligence

Regulatory & market intelligence for alternative tobacco & nicotine products

Business briefing

Global revenues down, but BAT enjoys 15% increase from ‘new categories’

Written by || 18th February 2021 || Business briefing | Heated tobacco | Snus and oral |

BAT delivered similar results in 2020 to the previous year despite the pandemic and a slip in its heated tobacco portfolio – boosted by growth in its oral tobacco products in the second half of the year ...

Restricted content. Do you want to read more?

Read our latest free content

US FDA authorises sale of oral tobacco products taken off the market in 2019
Decision on e-cigs shines some light on US FDA’s likely approach to alternatives
PMI’s heated tobacco business on the up despite warnings of disruption in US
Patents for HnB and smokeless tobacco products on the rise, research finds
‘Utopian’ – but is a global consensus on smoke-free alternatives a realistic goal?
What e-cigarette process tells us about the US FDA’s thinking on tobacco

Featured topic

The shift of the Mexican government toward allowing the sale of these smoke-free devices

A step forward on heated tobacco taken by the US Food and Drug Administration (FDA)

Blog| Regulatory Briefing | Heated tobacco

Sign up to our newsletter

By signing up you agree to our Terms and Conditions